| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Kyoto University; and the 2 Department of Ophthalmology, Nagoya City University Medical School, Japan.
Abstract
PURPOSE. To investigate the distribution of inflammatory mediators such as
interleukin (IL)-1ß and tumor necrosis factor (TNF)-
and
angiogenic cytokines such as vascular endothelial growth factor (VEGF)
and to identify their cellular source in surgically excised choroidal
neovascular membranes (CNVMs) of various ORIGINS. METHODS. Immunoperoxidase staining was performed on paraffin-embedded sections
of 11 surgically excised CNVMs to identify cellular distribution and
localization of cytokines. Immunofluorescent double staining was
performed to detect the cellular source of CYTOKINES. RESULTS. Cytokeratin-positive cells were detected in the RPE layer, in stromal
cells, and around neovascular vessels. Macrophages identified by their
cellular marker CD68 showed almost the same distribution as
cytokeratin-positive cells, although they were most prominent in the
stroma. A substantial number of neovascular vessels were also
immunoreactive to IL-1ß and TNF-. Immunofluorescent double
staining revealed that the RPE layers immunopositive for cytokeratin
were also immunopositive for all cytokines, whereas stromal cells
immunostained for CD68 were positive for IL-1ß and TNF-, but not
for VEGF. CONCLUSIONS. These results indicate that IL-1ß and TNF- secreted by macrophages
may promote, at least in part, angiogenesis in CNVMs by stimulating
VEGF production in RPE cells.
This article has been cited by other articles:
|
|
 |
|
  P. Yang, J. Tyrrell, I. Han, and G. J. Jaffe Expression and Modulation of RPE Cell Membrane Complement Regulatory Proteins Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3473 - 3481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakai, M. S. Rogers, T. Baba, T. Funakoshi, A. E. Birsner, D. S. Luyindula, and R. J. D'Amato Genetic loci that control the size of laser-induced choroidal neovascularization FASEB J, July 1, 2009; 23(7): 2235 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lebrun-Julien, L. Duplan, V. Pernet, I. Osswald, P. Sapieha, P. Bourgeois, K. Dickson, D. Bowie, P. A. Barker, and A. Di Polo Excitotoxic Death of Retinal Neurons In Vivo Occurs via a Non-Cell-Autonomous Mechanism J. Neurosci., April 29, 2009; 29(17): 5536 - 5545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tatar, A. Adam, K. Shinoda, E. Kaiserling, V. Boeyden, C. Claes, C. Eckardt, T. Eckert, G. Pertile, G. B. Scharioth, et al. Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization Arch Ophthalmol, March 1, 2009; 127(3): 275 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Tatar, K Shinoda, E Kaiserling, C Claes, C Eckardt, T Eckert, G Pertile, V Boeyden, G B Scharioth, E Yoeruek, et al. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation Br. J. Ophthalmol., February 1, 2009; 93(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schroedl, A. Brehmer, W. L. Neuhuber, F. E. Kruse, C. A. May, and C. Cursiefen The Normal Human Choroid Is Endowed with a Significant Number of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1)-Positive Macrophages Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5222 - 5229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakashizuka, M. Mitsumata, S. Okisaka, H. Shimada, A. Kawamura, R. Mori, and M. Yuzawa Clinicopathologic Findings in Polypoidal Choroidal Vasculopathy Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4729 - 4737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Su, E. A. Mendoza, H.-i. Kwak, and K. J. Bayless Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1215 - C1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Piermarocchi, M. Sartore, G. Lo Giudice, V. Maritan, E. Midena, and T. Segato Combination of Photodynamic Therapy and Intraocular Triamcinolone for Exudative Age-Related Macular Degeneration and Long-Term Chorioretinal Macular Atrophy Arch Ophthalmol, October 1, 2008; 126(10): 1367 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Davies, A. J. Stempel, and M. R. Powers MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4195 - 4202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakai, O. Fainaru, L. Bazinet, P. Pakneshan, O. Benny, E. Pravda, J. Folkman, and R. J. D'Amato Dendritic Cells Augment Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3666 - 3670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Noda, H. She, T. Nakazawa, T. Hisatomi, S. Nakao, L. Almulki, S. Zandi, S. Miyahara, Y. Ito, K. L. Thomas, et al. Vascular adhesion protein-1 blockade suppresses choroidal neovascularization FASEB J, August 1, 2008; 22(8): 2928 - 2935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A C Browning, H S Dua, and W M Amoaku The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells Br. J. Ophthalmol., July 1, 2008; 92(7): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Koyama, S. Matsuzaki, F. Gomi, K. Yamada, T. Katayama, K. Sato, T. Kumada, A. Fukuda, S. Matsuda, Y. Tano, et al. Induction of Amyloid {beta} Accumulation by ER Calcium Disruption and Resultant Upregulation of Angiogenic Factors in ARPE19 Cells Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2376 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, A. Adam, K. Shinoda, C. Eckardt, V. Boeyden, C. Claes, G. Pertile, et al. Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization Arch Ophthalmol, June 1, 2008; 126(6): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, S. Ohno, Y. Oike, and S. Ishida Inhibition of Choroidal Neovascularization with an Anti-Inflammatory Carotenoid Astaxanthin Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1679 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lu, L. Li, K. Kuno, Y. Wu, T. Baba, Y.-y. Li, X. Zhang, and N. Mukaida Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression J. Immunol., March 15, 2008; 180(6): 4283 - 4291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inoue, Y. Yanagi, K. Matsuura, H. Takahashi, Y. Tamaki, and M. Araie Expression of hypoxia-inducible factor 1{alpha} and 2{alpha} in choroidal neovascular membranes associated with age-related macular degeneration Br. J. Ophthalmol., December 1, 2007; 91(12): 1720 - 1721. [Full Text] [PDF]
|
|
|
|
|
|
H. Mochimaru, N. Nagai, G. Hasegawa, C. Kudo-Saito, T. Yaguchi, Y. Usui, T. Kurihara, T. Koto, S. Satofuka, H. Shinoda, et al. Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2 Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4795 - 4801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al. Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Olson, R. J. Courtney, and N. Mandava Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model Arch Ophthalmol, September 1, 2007; 125(9): 1221 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yang, J. J. Peairs, R. Tano, N. Zhang, J. Tyrell, and G. J. Jaffe Caspase-8-Mediated Apoptosis in Human RPE Cells Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3341 - 3349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-M. Bian, S. G. Elner, and V. M. Elner Thrombin-Induced VEGF Expression in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2738 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. She, T. Nakazawa, A. Matsubara, T. Hisatomi, T. A. Young, N. Michaud, E. Connolly, A. Hafezi-Moghadam, E. S. Gragoudas, and J. W. Miller Reduced Photoreceptor Damage after Photodynamic Therapy through Blockade of Nitric Oxide Synthase in a Model of Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2268 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al. Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2321 - 2326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kamei, K. Yoneda, N. Kume, M. Suzuki, H. Itabe, K.-i. Matsuda, T. Shimaoka, M. Minami, S. Yonehara, T. Kita, et al. Scavenger Receptors for Oxidized Lipoprotein in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1801 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagai, Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, T. Suda, et al. Angiotensin II Type 1 Receptor-Mediated Inflammation Is Required for Choroidal Neovascularization Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2252 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Zambarakji, T. Nakazawa, E. Connolly, A. M. Lane, S. Mallemadugula, M. Kaplan, N. Michaud, A. Hafezi-Moghadam, E. S. Gragoudas, and J. W. Miller Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2623 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Freund, C. M. Klais, C. M. Eandi, M. D. Ober, D. E. Goldberg, J. A. Sorenson, and L. A. Yannuzzi Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol, April 1, 2006; 124(4): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zarbin Should corticosteroids be considered as part of the standard care with photodynamic therapy? Arch Ophthalmol, April 1, 2006; 124(4): 563 - 571. [Full Text] [PDF]
|
|
|
|
|
|
A Hogan, U Behan, and D J Kilmartin Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation Br. J. Ophthalmol., September 1, 2005; 89(9): 1109 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Strauss The Retinal Pigment Epithelium in Visual Function Physiol Rev, July 1, 2005; 85(3): 845 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yang, J. L. Wiser, J. J. Peairs, J. N. Ebright, Z. J. Zavodni, C. Bowes Rickman, and G. J. Jaffe Human RPE Expression of Cell Survival Factors Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1755 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Honjo, T. Sawamura, J. Hinagata, K. Nakamura, N. Sanada, H. Tanihara, Y. Honda, and J. Kiryu Expression of LOX-1, an Oxidized Low-Density Lipoprotein Receptor, in Choroidal Neovascularization Arch Ophthalmol, December 1, 2004; 122(12): 1873 - 1876. [Full Text] [PDF]
|
|
|
|
|
|
A A Okada, T Wakabayashi, E Kojima, Y Asano, and T Hida Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation Br. J. Ophthalmol., August 1, 2004; 88(8): 1097 - 1098. [Full Text] [PDF]
|
|
|
|
|
|
P. Yang, B. S. McKay, J. B. Allen, and G. J. Jaffe Effect of NF-{kappa}B Inhibition on TNF-{alpha}-Induced Apoptosis in Human RPE Cells Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2438 - 2446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Cousins, D. G. Espinosa-Heidmann, and K. G. Csaky Monocyte Activation in Patients With Age-Related Macular Degeneration: A Biomarker of Risk for Choroidal Neovascularization? Arch Ophthalmol, July 1, 2004; 122(7): 1013 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Zarbin Current Concepts in the Pathogenesis of Age-Related Macular Degeneration Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sakurai, A. Anand, B. K. Ambati, N. van Rooijen, and J. Ambati Macrophage Depletion Inhibits Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3578 - 3585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Espinosa-Heidmann, I. J. Suner, E. P. Hernandez, D. Monroy, K. G. Csaky, and S. W. Cousins Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3586 - 3592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tsutsumi, K.-H. Sonoda, K. Egashira, H. Qiao, T. Hisatomi, S. Nakao, M. Ishibashi, I. F. Charo, T. Sakamoto, T. Murata, et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization J. Leukoc. Biol., July 1, 2003; 74(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lambert, C. Munaut, M. Jost, A. Noel, Z. Werb, J.-M. Foidart, and J.-M. Rakic Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization Am. J. Pathol., October 1, 2002; 161(4): 1247 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Penfold, L. Wen, M. C. Madigan, N. J. C. King, and J. M. Provis Modulation of Permeability and Adhesion Molecule Expression by Human Choroidal Endothelial Cells Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3125 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Espinosa-Heidmann, I. Suner, E. P. Hernandez, W. D. Frazier, K. G. Csaky, and S. W. Cousins Age as an Independent Risk Factor for Severity of Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1567 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D N PARMAR, R H Y ASARIA, P LUTHERT, and D G CHARTERIS Choroidal neovascularisation at a demarcation line: an immunopathological study Br. J. Ophthalmol., August 1, 2000; 84(8): 928a - 928. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
